Search Results - "Annals of hematology"
-
1
Mechanism of thrombocytopenia in COVID-19 patients
Published in Annals of hematology (01-06-2020)“…Since December 2019, a novel coronavirus has spread throughout China and across the world, causing a continuous increase in confirmed cases within a short…”
Get full text
Journal Article -
2
Blood type and outcomes in patients with COVID-19
Published in Annals of hematology (01-09-2020)“…This study aimed to determine if there is an association between ABO blood type and severity of COVID-19 defined by intubation or death as well as ascertain if…”
Get full text
Journal Article -
3
COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry
Published in Annals of hematology (01-02-2021)“…Introduction Since the early SARS-CoV-2 pandemic, cancer patients have been assumed to be at higher risk for severe COVID-19. Here, we present an analysis of…”
Get full text
Journal Article -
4
Hematological findings in coronavirus disease 2019: indications of progression of disease
Published in Annals of hematology (01-07-2020)“…Coronavirus disease 2019 (COVID-19) is a new human infectious disease. The etiology for this outbreak is a novel coronavirus named severe acute respiratory…”
Get full text
Journal Article -
5
Copper deficiency anemia: review article
Published in Annals of hematology (01-09-2018)“…Copper is a crucial micronutrient needed by animals and humans for proper organ function and metabolic processes such as hemoglobin synthesis, as a…”
Get full text
Journal Article -
6
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Published in Annals of hematology (01-02-2018)“…Immunocompromised patients are at high risk of invasive fungal infections (IFI), in particular those with haematological malignancies undergoing…”
Get full text
Journal Article -
7
Signals of Th2 immune response from COVID-19 patients requiring intensive care
Published in Annals of hematology (01-06-2020)Get full text
Journal Article -
8
Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry
Published in Annals of hematology (01-07-2020)“…The International Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry (NCT01374360) was initiated to optimize patient management by collecting data regarding…”
Get full text
Journal Article -
9
Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
Published in Annals of hematology (01-01-2021)“…Cancer patients frequently require central venous catheters for therapy and parenteral nutrition and are at high risk of central venous catheter–related…”
Get full text
Journal Article -
10
Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)
Published in Annals of hematology (01-05-2019)“…Sepsis and septic shock are major causes of mortality during chemotherapy-induced neutropenia for malignancies requiring urgent treatment. Thus, awareness of…”
Get full text
Journal Article -
11
COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure
Published in Annals of hematology (01-08-2020)“…COVID-19 pandemia is a major health emergency causing hundreds of deaths worldwide. The high reported morbidity has been related to hypoxia and inflammation…”
Get full text
Journal Article -
12
Clozapine-induced agranulocytosis
Published in Annals of hematology (01-11-2020)“…Wider use of clozapine, one of the most effective antipshychotic drugs, is precluded by its propensity to cause agranulocytosis. Currently, clozapine is used…”
Get full text
Journal Article -
13
Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States
Published in Annals of hematology (01-07-2015)“…Over half of patients diagnosed with acute myeloid leukemia (AML) are 65 years or older. We examined patient characteristics, treatment patterns, and survival…”
Get full text
Journal Article -
14
Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
Published in Annals of hematology (01-11-2017)“…Fever may be the only clinical symptom at the onset of infection in neutropenic cancer patients undergoing myelosuppressive chemotherapy. A prompt and…”
Get full text
Journal Article -
15
Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes
Published in Annals of hematology (01-03-2022)“…CC-90002 is an anti-CD47 antibody that inhibits CD47-SIRPα interaction and enables macrophage-mediated killing of tumor cells in hematological cancer cell…”
Get full text
Journal Article -
16
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)
Published in Annals of hematology (01-12-2017)“…We describe genetic and clinical characteristics of acute myeloid leukemia (AML) patients according to age from an academic population-based registry. Adult…”
Get full text
Journal Article -
17
Hematologic disorders associated with COVID-19: a review
Published in Annals of hematology (01-02-2021)“…Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2. Primarily an infection of the lower respiratory tract, it is now well…”
Get full text
Journal Article -
18
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
Published in Annals of hematology (01-09-2016)“…Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT) remain a clinical challenge. This is a guideline provided by the…”
Get full text
Journal Article -
19
Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy
Published in Annals of hematology (01-07-2019)“…The CD19-targeted chimeric antigen receptor T cell (CAR-T) therapy has been widely proved effective on relapsed and refractory (r/r) B cell acute lymphoblastic…”
Get full text
Journal Article -
20
Management of myelofibrosis after ruxolitinib failure
Published in Annals of hematology (01-06-2020)“…Myelofibrosis is a BCR-ABL1–negative myeloproliferative neoplasm characterized by anemia, progressive splenomegaly, extramedullary hematopoiesis, bone marrow…”
Get full text
Journal Article